Quick Answer
CROSS COUNTRY HEALTHCARE INC reported Stockholders Equity of $322.82 million for the year ending 2025.
- CROSS COUNTRY HEALTHCARE INC showed a decrease of -22.9% in Stockholders Equity from 2024 to 2025.
- This data is from CROSS COUNTRY HEALTHCARE INC's annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $249.28 million | Q3 2011: $251.10 million | Q1 2012: $249.54 million | Q2 2012: $234.48 million | Q3 2012: $218.19 million | Q1 2013: $213.24 million | Q2 2013: $211.55 million | Q3 2013: $212.77 million | Q1 2014: $160.27 million | Q2 2014: $156.95 million | Q3 2014: $149.71 million | Q1 2015: $133.14 million | Q2 2015: $136.12 million | Q3 2015: $141.55 million | Q1 2016: $160.30 million | Q2 2016: $143.81 million | Q3 2016: $158.70 million | Q1 2017: $195.28 million | Q2 2017: $200.95 million | Q3 2017: $208.70 million | Q1 2018: $235.50 million | Q2 2018: $236.27 million | Q3 2018: $236.61 million | Q1 2019: $215.32 million | Q2 2019: $163.96 million | Q3 2019: $162.89 million | Q1 2020: $160.76 million | Q2 2020: $148.65 million | Q3 2020: $148.41 million | Q1 2021: $173.14 million | Q2 2021: $191.60 million | Q3 2021: $216.80 million | Q1 2022: $356.07 million | Q2 2022: $410.81 million | Q3 2022: $422.71 million | Q1 2023: $451.93 million | Q2 2023: $464.61 million | Q3 2023: $463.92 million | Q1 2024: $462.45 million | Q2 2024: $433.32 million | Q3 2024: $424.69 million | Q1 2025: $418.21 million | Q2 2025: $412.24 million | Q3 2025: $408.14 million.
- Over the full 18 years of available data (2008 to 2025), CROSS COUNTRY HEALTHCARE INC's Stockholders Equity has grown by 37.9%.
- Historical annual values: Fiscal year 2025: $322.82 million | Fiscal year 2024: $418.96 million | Fiscal year 2023: $467.65 million | Fiscal year 2022: $451.48 million | Fiscal year 2021: $294.27 million | Fiscal year 2020: $154.38 million | Fiscal year 2019: $162.63 million | Fiscal year 2018: $217.53 million | Fiscal year 2017: $237.09 million | Fiscal year 2016: $151.24 million | Fiscal year 2015: $140.85 million | Fiscal year 2014: $129.88 million | Fiscal year 2013: $160.67 million | Fiscal year 2012: $209.12 million | Fiscal year 2011: $249.30 million | Fiscal year 2010: $246.01 million | Fiscal year 2009: $246.07 million | Fiscal year 2008: $234.02 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: